
Scholar Rock is a biopharmaceutical company specializing in discovering and developing innovative therapies for serious diseases with high unmet needs. Focused on the biology of transforming growth factor beta (TGFβ) superfamily proteins, Scholar Rock has created a pipeline targeting neuromuscular disease, cardiometabolic disorders, cancer, and other conditions. The company is distinguished by its proprietary platform that develops novel monoclonal antibodies for precise protein growth factor modulation, offering transformative treatments like muscle-targeted therapies for spinal muscular atrophy (SMA).
Scholar Rock is a biopharmaceutical company seeking a Vice President, Market Access, EMEA to lead value and access submission and negotiation planning. The role involves shaping access strategy, establishing sustainable access in European markets, and collaborating with global teams to achieve growth and improve patient outcomes. It's a key position on the Europe Region leadership team, impacting strategy, execution, and long-term growth.
Scholar Rock is a biopharmaceutical company specializing in discovering and developing innovative therapies for serious diseases with high unmet needs. Focused on the biology of transforming growth factor beta (TGFβ) superfamily proteins, Scholar Rock has created a pipeline targeting neuromuscular disease, cardiometabolic disorders, cancer, and other conditions. The company is distinguished by its proprietary platform that develops novel monoclonal antibodies for precise protein growth factor modulation, offering transformative treatments like muscle-targeted therapies for spinal muscular atrophy (SMA).